scispace - formally typeset
C

Christina Wang

Researcher at Los Angeles Biomedical Research Institute

Publications -  450
Citations -  30621

Christina Wang is an academic researcher from Los Angeles Biomedical Research Institute. The author has contributed to research in topics: Testosterone (patch) & Sperm. The author has an hindex of 88, co-authored 422 publications receiving 27941 citations. Previous affiliations of Christina Wang include Queen Mary University of London & Cedars-Sinai Medical Center.

Papers
More filters
Journal ArticleDOI

Chapter 1: pathophysiology of hypopituitarism in the setting of brain injury

Joshua R. Dusick, +6 more
- 01 Mar 2012 - 
TL;DR: The hypotheses and available data concerning hypothalamic-pituitary vulnerability in the setting of head injury are discussed and four possible pathophysiological mechanisms are considered: the primary brain injury event, secondary brain insults, the stress of critical illness and medication effects.
Journal ArticleDOI

Effect of acute myocardial infarction on pituitary‐testicular function

Christina Wang, +3 more
- 01 Sep 1978 - 
TL;DR: The data suggest that following the medical stress of myocardial infarction, testosterone concentration was suppressed resulting in a compensatory rise in LH.
Journal ArticleDOI

Prolactin inhibition of estrogen production by cultured rat granulosa cells.

Christina Wang, +2 more
- 01 Nov 1980 - 
TL;DR: It is demonstrated that PRL acts directly on rat granulosa cells in vitro to suppress basal and gonadotropin-induced increases in estrogen production and causes a dose-related increase in progesterone and 20 alpha-dihydroprogesterone secretion.
Journal ArticleDOI

The effect of heroin addiction on pituitary‐testicular function

Christina Wang, +2 more
- 01 Nov 1978 - 
TL;DR: The effect of heroin addiction on pituitary‐testicular function was studied in 54 active and 19 abstinent addicts and their results were compared with those of 43 age‐matched controls.
Journal ArticleDOI

Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone

I. T. Gaw Gonzalo, +6 more
- 01 Aug 2002 - 
TL;DR: It is concluded that Norplant II implants plus TE 100 mg/wk were very efficient in suppressing spermatogenesis and the dose or dose of administration of androgens is critical for sperm suppression in normal men.